Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells
- 7 September 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 336 (4) , 1005-1009
- https://doi.org/10.1016/j.bbrc.2005.08.225
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Beyond lipid lowering: the role of statins in vascular protectionInternational Journal of Cardiology, 2002
- 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase InhibitorsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- HMG‐CoA reductase inhibition protects the diabetic myocardium from ischemia‐reperfusion injuryThe FASEB Journal, 2001
- Inhibition of endothelial cell migration by cerivastatin, an HMG‐CoA reductase inhibitor: contribution to its anti‐angiogenic effectFEBS Letters, 2001
- Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the ratBritish Journal of Pharmacology, 2000
- Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthaseProceedings of the National Academy of Sciences, 1998
- Pravastatin Has Cholesterol-Lowering Independent Effects on the Artery Wall of Atherosclerotic MonkeysJournal of the American College of Cardiology, 1998
- Statins do more than just lower cholesterolThe Lancet, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995